venBio Partners LLC - Q4 2022 holdings

$323 Million is the total value of venBio Partners LLC's 7 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 12.5% .

 Value Shares↓ Weighting
SellVENTYX BIOSCIENCES INC$113,503,765
-35.1%
3,461,536
-30.9%
35.19%
-13.1%
ALXO  ALX ONCOLOGY HLDGS INC$109,318,155
+17.8%
9,699,9250.0%33.89%
+57.8%
HRMY SellHARMONY BIOSCIENCES HLDGS IN$57,050,320
+14.4%
1,035,396
-8.0%
17.69%
+53.3%
PHVS  PHARVARIS N V$25,837,988
+46.7%
2,296,7100.0%8.01%
+96.5%
IMPL  IMPEL PHARMACEUTICALS INC$10,349,216
-23.0%
2,759,7910.0%3.21%
+3.2%
SellCINCOR PHARMA INC$4,711,863
-92.3%
383,390
-79.4%
1.46%
-89.7%
ELEV  ELEVATION ONCOLOGY INC$1,773,022
-15.9%
1,866,3390.0%0.55%
+12.7%
AKRO ExitAKERO THERAPEUTICS INC$0-596,483
-100.0%
-4.70%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERONA PHARMA PLC15Q2 202222.2%
AKERO THERAPEUTICS INC14Q3 202265.3%
ALX ONCOLOGY HLDGS INC13Q3 202373.8%
HARMONY BIOSCIENCES HLDGS IN13Q3 202321.1%
APELLIS PHARMACEUTICALS INC11Q2 202162.0%
PHARVARIS N V11Q3 202325.2%
IMPEL PHARMACEUTICALS INC10Q3 20237.3%
ELEVATION ONCOLOGY INC10Q3 20234.2%
VENTYX BIOSCIENCES INC8Q3 202342.7%
PRECISION BIOSCIENCES INC7Q3 202062.0%

View venBio Partners LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View venBio Partners LLC's complete filings history.

Compare quarters

Export venBio Partners LLC's holdings